|
⚲
|
| Keyboard |
| Leschly Jan
✚
|
|
|---|---|
| CIK # | 0001204568 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001204568] | |
| 4 | [0001204568] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Leschly Jan | |
| NABI Biopharmaceuticals | |
| American Express Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals AVIR
Common Stock
|
2018-02-13 | Grant | 30,793,670 | ||
|
American Express Co AXP
Common Stock
|
2012-11-19 | Sell | 35,250 | $55.10 | 1,942,275 |
|
American Express Co AXP
Common Stock
|
2012-11-19 | Buy | 35,250 | $55.17 | 1,944,742 |
|
American Express Co AXP
Common Stock
|
2012-11-19 | Buy | 35,250 | $55.16 | 1,944,390 |
|
American Express Co AXP
Common Stock
|
2012-11-19 | Sell | 35,250 | $55.08 | 1,941,570 |
|
American Express Co AXP
Share Equivalent Units · derivative
|
2012-05-10 | Grant | 2,593.90 | $0.00 | |
|
American Express Co AXP
Common Stock
|
2012-02-29 | Sell | 3,427 | $53.43 | 183,105 |
|
American Express Co AXP
Director Stock Option (Right to Buy) · derivative
|
2012-02-29 | Option exercise | 3,427 | $0.00 | |
|
American Express Co AXP
Common Stock
|
2012-02-29 | Option exercise | 3,427 | $37.71 | 129,232 |